PMV Pharmaceuticals (PMVP) vs Quantum Cyber N.V. (QUCY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
PMV Pharmaceuticals (PMVP) has outperformed Quantum Cyber N.V. (QUCY) over the past year, gaining 4.9% versus a loss of 13.1%. Quantum Cyber N.V. is the larger company by market cap ($116.9 million vs $112.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | PMVP | QUCY |
|---|---|---|
| Share price | $1.49 | $1.39 |
| Market cap | $112.51M | $116.85M |
| 1-day change | -0.67% | -2.80% |
| YTD return | +19.20% | +24.11% |
| 1-year return | +4.93% | -13.13% |
| 5-year return | -93.78% | — |
| EPS (TTM) | $-1.42 | $-2.41 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $1.91 | $4.93 |
| 52-week low | $1.02 | $0.30 |
| Distance from 52-week high | -21.99% | -71.81% |
| Analyst consensus | none | none |
| Avg. price target upside | +181.88% | +547.48% |
| Average volume | 661.39K | 691.24K |
| Shares outstanding | 75.51M | 84.07M |
| Employees | 54 | 10 |
| Sector | Healthcare | Health Care |
| Industry | Biotechnology | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PMVP has outperformed QUCY by 18.1 percentage points over the past year.
- The two companies sit in different sectors: PMV Pharmaceuticals in Healthcare and Quantum Cyber N.V. in Health Care.
About PMV Pharmaceuticals
PMVP stock →PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule therapies targeting p53 mutations and other p53-related cancers in the United States. It develops rezatapopt, a selective structural corrector of p53 Y220C mutations in Phase 2 clinical trials for tumor agnostic diseases.
Healthcare · Biotechnology · 54 employees
About Quantum Cyber N.V.
QUCY stock →Quantum Cyber N.V. operates as a technology company focused on cybersecurity and quantum computing solutions.
Health Care · Biotechnology: Pharmaceutical Preparations · 10 employees
PMVP vs QUCY FAQ
Which is bigger, PMV Pharmaceuticals or Quantum Cyber N.V.?
Quantum Cyber N.V. (QUCY) is larger, with a market capitalization of $116.85M compared with $112.51M for PMV Pharmaceuticals (PMVP).
Which stock has performed better over the past year, PMVP or QUCY?
PMVP returned +4.93% over the past 12 months, compared with -13.13% for QUCY (price return, excluding dividends). Past performance does not predict future results.
Are PMV Pharmaceuticals and Quantum Cyber N.V. in the same industry?
No. PMV Pharmaceuticals is in the Healthcare sector, while Quantum Cyber N.V. is in Health Care.